Klisyri
NDC 16110-391, tirbanibulin, ointment, from Almirall, LLC.
- Product NDC
- 16110-391
- Status
- Listed
- Labeler
- Almirall, LLC
- Dosage form
- OINTMENT
- Route
- TOPICAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA213189
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16110-391 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TIRBANIBULIN10 mg/g
Pharmacologic classes
Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16110-391-05 | 16110039105 | 5 PACKET in 1 CARTON (16110-391-05) / .25 g in 1 PACKET |
| 16110-391-55 | 16110039155 | 5 PACKET in 1 CARTON (16110-391-55) / .35 g in 1 PACKET |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/589c8de8-b773-4d47-b60c-48471806cccc
Use it
Look up 16110-391 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16110-391 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16110-391. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.